arrow
M

Maria De Bonis

molecular and genomic diagnostics
H指数:12
被引数:536

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Detection of Clinically Significant BRCA Large Genomic Rearrangements in FFPE Ovarian Cancer Samples: A Comparative NGS Study

临床意义显著BRCA大基因组重排的检测:一项比较NGS研究(在FFPE卵巢癌样本中)

2025-10-010
OAAI
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study

根据BRCA1/2突变类型和位点,在新诊断卵巢癌患者中从PARP抑制剂维持治疗中获益:一项多中心真实世界研究

2025-04-011
OAAI
Management Of A Patient With Ovarian Cancer Carried Of The BRCA2 P.R3052Q Variant: From Tissue To Liquid Biopsy To Clarify The Molecular Status Of The Patient

携带BRCA2 P.R3052Q变异的卵巢癌患者管理:从组织活检到液体活检,以明确患者的分子状态

2025-02-010
PRE
Identification of a False-positive Multiplex Ligation- dependent Probe Amplification Result in BRCA1 Using a Copy Number Variation Algorithm Under Development for a Commercial Next-Generation Sequencing-based Homologous Recombination Deficiency Assay
2024-05-310
OAAI
High throughput analysis in HER2 positive locally advanced breast cancer: pCR and mutational status
2024-05-020
PRE
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids
2023-05-1817
OAAI
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review
2015-08-2429
PREAI